RSV is growing in dozens of states and kids’ hospitals are watching capacity

Respiratory syncytial virus is once again tightening its grip across the country, and you are seeing the ripple effects in crowded pediatric emergency rooms and longer waits for hospital beds. As RSV activity climbs in dozens of states at the same time that flu and COVID are gaining steam, children’s hospitals are watching capacity day by day and sometimes hour by hour. The question for families and clinicians is no longer whether RSV will show up, but how hard it will hit and whether the system around you can absorb the surge.

RSV’s early climb and what the national outlook shows

You are heading into a respiratory season that federal forecasters expect to be intense but not unprecedented, with RSV playing a central role. In its qualitative assessment for the 2025 to 2026 season, the CDC projects that the peak weekly hospitalization rate across all age groups due to RSV will be similar to or slightly below some of the worst recent years, based on historical trends and recent surveillance data. That still translates into thousands of children and older adults needing inpatient care at roughly the same time, which is why you are hearing so much about capacity even before the season’s peak.

Earlier projections from late summer painted a similar picture, with the CDC’s Aug RSV outlook warning that the virus would remain a major driver of pediatric hospitalizations even as new immunization tools roll out, again based on expert opinion and historical patterns. For you, that means the national signal is clear: RSV is not fading into the background, and planning around it has to be as deliberate as planning around flu. When you hear that RSV is “growing” in your state, it is not a blip, it is part of a wave that federal modelers have been expecting for months.

How RSV interacts with flu and COVID in a crowded season

What makes this season particularly punishing for pediatric services is not RSV alone but the way it stacks on top of flu and COVID. National respiratory surveillance shows that, as of mid December, the amount of acute respiratory illness sending people to clinics and emergency rooms is climbing, with health officials emphasizing what you need to know as of December about overlapping viruses. When several pathogens surge together, you feel it in longer waits, more crowded waiting rooms, and more pressure on pediatric intensive care units.

Flu is already surging in parts of the country, and that matters for RSV capacity because the same pediatric wards and ICUs care for both sets of patients. In New Jersey the state health department has reported more than 11,000 cases of flu in a single week, while national updates describe RSV and COVID still at relatively low levels but pertussis and influenza rising sharply, with RSV and COVID both flagged by the CDC as viruses that spread easily from person to person. For your local children’s hospital, that combination means every RSV admission is competing for space with a growing number of flu and COVID cases.

State-by-state signals that RSV is spreading

When you hear that RSV is “growing in dozens of states,” that assessment is grounded in real-time modeling of how quickly infections are spreading. Federal analysts track the effective reproduction number, or R t, for each state and categorize whether a virus is expanding, stable, or shrinking, using a dashboard that lists every jurisdiction under an Epidemic Trends table with columns such as Location Sort and Epidemic Trend Category Sort. When RSV’s R t sits above 1 in a large share of states, it means each infection is leading to more than one new case, and you can expect hospitalizations to follow within a couple of weeks.

At the same time, state-level flu reports show how respiratory viruses rarely respect borders. National coverage has highlighted how Flu cases are on the rise across the US, with New York hitting a weekly case record and other states like Colorado and Louisiana also seeing steep climbs, while projections even extend to places like Hawaii, according to national flu reporting. For you, the takeaway is that once RSV starts accelerating in your region’s Epidemic Trend Category, it is unlikely to stay contained to a single metro area, and pediatric hospitals across your state will feel the strain together.

Why pediatric capacity is so fragile

You might assume that a large hospital system can simply flex up when RSV surges, but pediatric capacity is more brittle than it looks on paper. A cross-sectional study of pediatric bed capacity across 254 hospital referral regions found that a mean of 112 of those regions, or 44% of them, experienced bed strain defined as more than 85% bed occupancy. That level of crowding leaves very little room for a sudden influx of infants with RSV who may need oxygen, high-flow support, or intensive care.

The same research highlighted how load imbalance between hospitals can worsen your experience as a parent, because one facility might be overflowing while another across town still has open beds. When RSV admissions spike, that imbalance can translate into long ambulance transfers, children being boarded in emergency departments, or families being told they must travel hours away for a pediatric ICU bed, all while the system as a whole technically has capacity. For you, the practical implication is that RSV season is not just about how many children get sick, but about how evenly those cases are spread across the pediatric network that serves your region.

New RSV protections for infants and how hospitals use them

One of the most important shifts in RSV care over the past two seasons is the expansion of preventive antibodies for newborns. Federal data on Birthing Hospital Enrollment During the RSV Seasons show that among all 2,817 U.S. birthing hospitals, the majority are now enrolled to provide nirsevimab through the VFC program. For you as a parent, that means your baby is increasingly likely to receive RSV protection before leaving the hospital, especially if you deliver at a facility that has joined this effort.

National guidance has also become more explicit about who should receive these tools. In its Dec RSV outlook, the CDC notes that a long-acting monoclonal antibody is recommended for all infants, with nirsevimab recommended for all infants entering their first RSV season. Earlier, the CDC’s Aug RSV outlook emphasized that pediatric RSV immunizations will likely reduce hospitalizations but that immunity may wane over time, underscoring that pediatric RSV immunizations will likely lower risk but not eliminate it. For hospitals, these tools are not just about individual protection, they are a way to blunt the peak of admissions and keep pediatric wards from tipping into crisis.

Evidence that prevention is already easing the burden

You are not starting from scratch in this RSV season, because early data suggest that prevention is already sparing some babies from the worst outcomes. Advocacy groups working with clinicians report that during the 2024 to 2025 RSV season, expanded use of preventive antibodies and maternal vaccination translated into fewer infants struggling to breathe in emergency rooms and fewer parents facing the trauma of an ICU admission, according to new RSV prevention data. That kind of impact is exactly what pediatric hospitals are counting on as RSV spreads across multiple states at once.

For you, the message is that prevention is not an abstract public health slogan, it is a concrete way to keep your local children’s hospital from being overwhelmed. Every infant who avoids a severe RSV infection because of nirsevimab, maternal vaccination, or careful infection control at home is one less child competing for a scarce pediatric bed. When you talk with your obstetrician or pediatrician about RSV prevention, you are not only protecting your own baby, you are helping stabilize the system that other families will rely on when their child cannot breathe.

Flu’s rough year and what it means for kids’ wards

Even if RSV is your main worry for infants, flu is the virus that can quietly eat up pediatric capacity in older children. In some states, flu is hitting harder and earlier than in the past two years, with New Jersey the health department reporting that There were more than 11,000 cases of flu in a single recent week. When that many school-age children and teenagers fall ill at once, pediatric units that might otherwise be able to absorb an RSV surge find themselves juggling both viruses.

Nationally, flu cases are climbing fast, with reports of record weekly counts in New York and steep increases in states like Colorado and Louisiana, as well as projections that the wave will extend to Hawaii, according to coverage of the bad flu season. For your local children’s hospital, that means RSV is arriving in a landscape where beds are already filling with influenza pneumonia, asthma exacerbations triggered by flu, and complications in kids with chronic conditions. The more aggressively you pursue flu vaccination for your family, the more breathing room you help create for RSV patients who have no vaccine of their own.

How to recognize RSV and flu symptoms in your child

When RSV and flu are both circulating, you need a clear mental checklist for what to watch for in your child. RSV often starts like a mild cold, with a runny nose and low-grade fever, but in infants and toddlers it can quickly progress to wheezing, rapid breathing, flaring nostrils, or chest retractions, all signs that your child is working too hard to breathe. Public health guidance on respiratory season stresses that you should seek urgent care if you see those warning signs, especially in babies under six months, even as officials track what proportion of clinic visits are due to respiratory viruses.

Flu, by contrast, tends to hit older children with a sudden high fever, body aches, headache, and profound fatigue, and this year some states are reporting what they describe as a “Super flu” pattern of intense symptoms. Local coverage has highlighted that RSV is also at a high level in several regions, with reporters spelling out flu and RSV symptoms and how to protect yourself. For you, the practical move is to keep a low threshold for calling your pediatrician when your child has trouble breathing, is not drinking enough, or seems unusually lethargic, regardless of which virus is to blame.

Vaccines, antibodies, and what you can do now

You have more tools than ever to blunt the impact of this respiratory season, even if RSV itself does not yet have a widely used pediatric vaccine. For flu, experts are urging vaccination despite the emergence of a new variant known as subclade K, noting that Despite the emergence of subclade K, the vaccine is expected to reduce the risk of severe illness and hospitalization. For COVID, the CDC’s Aug COVID outlook anticipates that the peak weekly hospitalization rate for the 2025 to 2026 season will be lower than in the earliest pandemic years, but still significant enough that COVID vaccination remains a key layer of protection for families.

For RSV specifically, your main options are maternal vaccination during pregnancy and long-acting antibodies for infants, both of which are now embedded in hospital routines. National RSV prevention data emphasize that these tools have already led to fewer babies struggling to breathe in emergency rooms, and experts are urging parents to talk with their healthcare providers to discuss prevention, as highlighted in recent prevention reports. When you combine those medical tools with simple steps like keeping sick siblings away from newborns, improving ventilation at home, and masking in crowded indoor spaces during peak weeks, you are not only lowering your child’s risk, you are helping your community’s children’s hospital stay open for the emergencies that cannot be prevented.